For once I think Adam Fraudsteen has a valid point regarding potential difficulties that MNKD management could be facing in trying to partner. A complete buyout would simplify the negotiations, but I do not understand what the heck Greenhill has done to provide potential prospects. One would think that with the months that Greenhill has been at it, the field of partners/buyers would be resolved. Unfortunately, as much as I despise Adam F, I believe he's on target!
AF has failed to provide the strengths that Afrezza could bring to the party. Any serious analysis has to assess strengths as well as weaknesses in making a judgment. In my opinion, has considerable strengths that would give Afrezza key proprietary advantages over competition. I have noted them before as have many on this board so I won't belabor them. Furthermore, he has totally ignored the value of technosphere to potential partners. His comments appear to be falling on deaf ears today - and rightly so.
Agreed! MNKD's cash position DOES NOT force them into a bad deal! Label is fine, and can't even believe he brought up the Cancer arguement!
And if I see us compared to exhubera 1 more time, I think I might smash my computer!!
The ironic thing is even though Exhubera was an inferior product, ny doctor had several patients on it that loved it!
You have to constantly remind yourself that he predicted ADCOM non approval on same grounds and he was WRONG! He was sure of both T1 and T2 disapproval....Then his boss comes on his show and says Al Mann exceeded his expectations....Finally they went quiet while stock was trading pre approval even higher than today and come Monday , he regurgitates same garbage trying to keep PPS down.....Fortunately, this bashings are not having much impact....